| A path toward precision medicine for neuroinflammatory mechanisms in Alzheimer's disease H Hampel, F Caraci, AC Cuello, G Caruso, R Nisticò, M Corbo, F Baldacci, ... Frontiers in immunology 11, 456, 2020 | 236 | 2020 |
| Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's disease M Poletti, D Frosini, C Pagni, F Baldacci, V Nicoletti, G Tognoni, C Lucetti, ... Journal of Neurology, Neurosurgery & Psychiatry 83 (6), 601-606, 2012 | 198 | 2012 |
| Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study B Dubois, S Epelbaum, F Nyasse, H Bakardjian, G Gagliardi, ... The Lancet Neurology 17 (4), 335-346, 2018 | 195 | 2018 |
| Randomized trial on the effects of a combined physical/cognitive training in aged MCI subjects: the Train the Brain study Scientific Reports 7 (1), 39471, 2017 | 147 | 2017 |
| Revolution of Alzheimer precision neurology. Passageway of systems biology and neurophysiology H Hampel, N Toschi, C Babiloni, F Baldacci, KL Black, ALW Bokde, ... Journal of Alzheimer's Disease 64 (s1), S47-S105, 2018 | 146 | 2018 |
| Nuove osservazioni sul problema della Falda Toscana e sulla interpretazione dei flysch arenacei tipo “Macigno” dell’Appennino settentrionale F Baldacci Memorie della Società Geologica Italiana 6 (2), 213, 1967 | 144 | 1967 |
| Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease A Vergallo, L Mégret, S Lista, E Cavedo, H Zetterberg, K Blennow, ... Alzheimer's & Dementia 15 (6), 764-775, 2019 | 134 | 2019 |
| A single-center, cross-sectional prevalence study of impulse control disorders in Parkinson disease: association with dopaminergic drugs M Poletti, C Logi, C Lucetti, P Del Dotto, F Baldacci, A Vergallo, M Ulivi, ... Journal of clinical psychopharmacology 33 (5), 691-694, 2013 | 106 | 2013 |
| Precision pharmacology for Alzheimer’s disease H Hampel, A Vergallo, LF Aguilar, N Benda, K Broich, AC Cuello, ... Pharmacological research 130, 331-365, 2018 | 97 | 2018 |
| Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer’s disease and other neurodegenerative diseases F Baldacci, S Lista, E Cavedo, U Bonuccelli, H Hampel Expert review of proteomics 14 (4), 285-299, 2017 | 97 | 2017 |
| Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ1–42, total-tau, phosphorylated-tau, NFL … H Hampel, N Toschi, F Baldacci, H Zetterberg, K Blennow, I Kilimann, ... Alzheimer's & Dementia 14 (4), 492-501, 2018 | 94 | 2018 |
| Omics sciences for systems biology in Alzheimer’s disease: State-of-the-art of the evidence H Hampel, R Nisticò, NT Seyfried, AI Levey, E Modeste, P Lemercier, ... Ageing Research Reviews 69, 101346, 2021 | 90 | 2021 |
| Progression of brain atrophy in the early stages of Parkinson's disease: A longitudinal tensor‐based morphometry study in de novo patients without cognitive impairment C Tessa, C Lucetti, M Giannelli, S Diciotti, M Poletti, S Danti, F Baldacci, ... Human brain mapping 35 (8), 3932-3944, 2014 | 89 | 2014 |
| Sex differences in functional and molecular neuroimaging biomarkers of Alzheimer's disease in cognitively normal older adults with subjective memory complaints E Cavedo, PA Chiesa, M Houot, MT Ferretti, MJ Grothe, SJ Teipel, S Lista, ... Alzheimer's & Dementia 14 (9), 1204-1215, 2018 | 85 | 2018 |
| Migraine features in migraineurs with and without anxiety–depression symptoms: A hospital-based study F Baldacci, C Lucchesi, M Cafalli, M Poletti, M Ulivi, M Vedovello, ... Clinical neurology and neurosurgery 132, 74-78, 2015 | 77 | 2015 |
| Levodopa response in dementia with lewy bodies: a 1-year follow-up study C Lucetti, C Logi, P Del Dotto, C Berti, R Ceravolo, F Baldacci, C Dolciotti, ... Parkinsonism & related disorders 16 (8), 522-526, 2010 | 75 | 2010 |
| Low cognitive awareness, but not complaint, is a good marker of preclinical Alzheimer’s disease F Cacciamani, C Tandetnik, G Gagliardi, H Bertin, MO Habert, H Hampel, ... Journal of Alzheimer's Disease 59 (2), 753-762, 2017 | 66 | 2017 |
| α-Synuclein heterocomplexes with β-amyloid are increased in red blood cells of Parkinson’s disease patients and correlate with disease severity S Daniele, D Frosini, D Pietrobono, L Petrozzi, A Lo Gerfo, F Baldacci, ... Frontiers in Molecular Neuroscience 11, 53, 2018 | 58 | 2018 |
| Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer's disease S Lista, N Toschi, F Baldacci, H Zetterberg, K Blennow, I Kilimann, ... Neurochemistry international 108, 355-360, 2017 | 58 | 2017 |
| Two-level diagnostic classification using cerebrospinal fluid YKL-40 in Alzheimer's disease F Baldacci, N Toschi, S Lista, H Zetterberg, K Blennow, I Kilimann, ... Alzheimer's & Dementia 13 (9), 993-1003, 2017 | 52 | 2017 |
michele polettiDirigente Psicologo, USL Reggio EmiliaVerified email at ausl.re.it
